Tempus ECG-Low EF vs 1CMR Pro
AI Verdict
Choose Tempus ECG-Low EF if…
Choose Tempus ECG-Low EF if your goal is to rapidly screen a broad patient population (40+ years) for potential low left ventricular ejection fraction using readily available 12-lead ECGs, particularly in primary care, emergency medicine, or general cardiology settings. This tool is ideal for identifying patients at risk of heart failure who may require further, more definitive cardiac evaluation.
View Tempus ECG-Low EF →Choose 1CMR Pro if…
Choose 1CMR Pro if your facility regularly performs Cardiac MRI scans and requires enhanced precision, speed, and consistency in the analysis and reporting of these complex images. This software is best suited for specialized cardiology and radiology departments aiming to optimize detailed volumetric and functional measurements for diagnosis, treatment planning, and research.
View 1CMR Pro →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Tempus ECG-Low EF | 1CMR Pro |
|---|---|---|
| Pricing | Unknown | Contact for pricing |
| Deployment | Integrates with current ECG platforms and electronic health records (EHRs). | On-premise (software installed on hospital's own computer, processing data locally via a secure web-based platform) |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Tempus ECG-Low EFTempus ECG-Low EF (Tool A) is designed for integration into existing healthcare facility workflows and provides a simple binary output, suggesting a straightforward user experience for screening purposes. While 1CMR Pro (Tool B) offers detailed, editable contours for clinician control, its on-premise deployment and more complex reporting features might imply a steeper learning curve or more involved interaction.
Clinical Value
1CMR Pro1CMR Pro (Tool B) offers a quantifiable improvement in diagnostic precision, delivering up to 40% more precise measurements than manual analysis for Cardiac MRI, enhancing accuracy and consistency for a high-fidelity diagnostic tool. Tempus ECG-Low EF (Tool A) provides valuable early identification of patients at risk of heart failure using a common ECG, but its role is primarily for screening and aiding further evaluation, rather than providing a definitive, quantitatively more precise diagnosis.
Pricing & Value
TieBoth Tempus ECG-Low EF (Tool A) and 1CMR Pro (Tool B) require direct contact with the vendor for pricing information. Without publicly disclosed pricing details for either product, it is impossible to conduct a head-to-head comparison of their costs or assess their relative value propositions.
Enterprise Readiness
Tempus ECG-Low EFTempus ECG-Low EF (Tool A) explicitly states HIPAA compliance and the availability of a Business Associate Agreement (BAA), which are critical for enterprise adoption in healthcare. While 1CMR Pro (Tool B) emphasizes local data processing and ISO 27001 certification for security, it does not explicitly state HIPAA compliance or BAA availability for the product itself, which could be a barrier for some organizations.
Innovation
1CMR Pro1CMR Pro (Tool B) demonstrates significant innovation by achieving up to 40% higher precision than manual analysis in complex Cardiac MRI reporting, utilizing convolutional neural networks trained on extensive datasets and offering transparent, editable contours for clinician control. Tempus ECG-Low EF (Tool A) is innovative in applying AI to widely available ECG data for LVEF screening, but 1CMR Pro's quantifiable leap in diagnostic precision for a sophisticated imaging modality gives it an edge in technical innovation.
Support & Docs
TieThe provided structured facts and web searches did not yield specific information regarding the availability or quality of support and documentation for either Tempus ECG-Low EF (Tool A) or 1CMR Pro (Tool B). Therefore, a definitive comparison on this dimension cannot be made.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Tempus ECG-Low EF | 1CMR Pro |
|---|---|---|
| Tool Name | Tempus ECG-Low EF | 1CMR Pro |
| Company | Tempus AI | Mycardium AI Limited |
| Primary Function | Analyzes 12-lead ECG recordings to detect signs associated with low left ventricular ejection fraction (LVEF u226440%) | AI-enhanced Cardiac MRI reporting software for faster and more consistent cardiac MRI analysis |
| Target Patient Population/Data Type | Patients 40 years or older at risk of heart failure, using 12-lead ECG recordings | Cardiac MRI data |
| Key Output/Benefit | Binary output (Low LVEF Detected / Not Detected) to aid clinicians in further evaluation | Up to 40% more precise measurements, enabling faster and more consistent cardiac MRI analysis |
Videos
Demos, reviews, and walkthroughs featuring Tempus ECG-Low EF and 1CMR Pro.
Frequently Asked Questions
More Comparisons
More matchups featuring Tempus ECG-Low EF or 1CMR Pro
Backers
Who funded each tool's parent company.